milion, a 9.1% increase YoY as planned reflected stable growth from both volume and price Share of Profit (Power Business) increased 166.4% YoY from 3Q2016 to record at Baht 553.8 million with foreign
2Q2018, Share of Profit from Investments in Associates and Joint Ventures was Baht 246.8 million, a 64.0% decrease from Baht 685.9 million in 2Q2017 with Foreign Exchange Loss of Baht (315.3) million in
currency exchange for Q3 2023 was mainly associated with the USD loan related to the SGAH transaction and was non-cash in nature. Share of profit (loss) from investment in associates and joint venture was at
Q2/2020 (Ending June 30, 2020) To Director and Manager of the Stock Exchange of Thailand UBIS (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial
recorded its year-to-date market share in terms of retail sales volume at 15.8%, or at the 2nd rank, and continue to increase the shares. Total marketing sales volume reduced from the intensifying
more than 20% To : President The Stock Exchange of Thailand Global Service Center Public Company Limited (“the Company”) would like to inform that the Company has already disclosed financial statements
volume raised from 0.21 to 14.78 million shares. Earlier, the SEC had proceeded with the settlement process where the wrongdoers in UNIQ share price manipulation case were fined over 80.9 million baht
Profits increased 40% to THB 539m in Q2 2017 from THB 384m in Q2 2016. Net Profit increased 62% to THB 676m in Q217 from THB 417m in Q216, due to higher operating profits and exchange gain in Q217. Quarter
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
foreign exchange 299 (39) 230 N/A N/A 663 363 N/A (loss) from impairment of assets (1,358) (412) (14) N/A N/A (1,441) (425) N/A Share of profit of associate and JV 56 23 118 111% 413% 128 233 82% Profit